| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
PharmaEssentia Corporation (TWO: 6446)
6446 Technical Analysis
5
| As on 26th Mar 2024 6446 STOCK Price closed @ 318.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 429.80 & Strong Sell for SHORT-TERM with Stoploss of 501.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
6446STOCK Price
| Open | 328.00 | Change | Price | % |
| High | 328.00 | 1 Day | -7.50 | -2.30 |
| Low | 316.00 | 1 Week | -8.50 | -2.60 |
| Close | 318.00 | 1 Month | 4.00 | 1.27 |
| Volume | 1354347 | 1 Year | -258.00 | -44.79 |
| 52 Week High 591.00 | 52 Week Low 283.00 | ||||
TWO Taiwan Most Active Stocks
| 1815 | 84.40 | -1.29% |
| 5309 | 71.70 | 2.87% |
| 5498 | 29.40 | 2.44% |
| 3105 | 182.00 | 4.90% |
| 8358 | 268.50 | -2.72% |
| 1785 | 64.70 | 1.89% |
| 8074 | 39.50 | 3.95% |
| 4979 | 260.50 | 2.76% |
| 6290 | 183.50 | -2.39% |
| 3260 | 185.50 | 1.92% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 6446 Daily Charts |
6446 Intraday Charts |
Whats New @ Bazaartrend |
6446 Free Analysis |
|
|
6446 Important Levels Intraday
| RESISTANCE | 341.12 |
| RESISTANCE | 333.71 |
| RESISTANCE | 329.12 |
| RESISTANCE | 324.54 |
| SUPPORT | 311.46 |
| SUPPORT | 306.88 |
| SUPPORT | 302.29 |
| SUPPORT | 294.88 |
6446 Forecast December 2025
| 4th UP Forecast | 568.51 |
| 3rd UP Forecast | 488.17 |
| 2nd UP Forecast | 438.51 |
| 1st UP Forecast | 388.85 |
| 1st DOWN Forecast | 247.15 |
| 2nd DOWN Forecast | 197.49 |
| 3rd DOWN Forecast | 147.83 |
| 4th DOWN Forecast | 67.49 |
6446 Weekly Forecast
| 4th UP Forecast | 510.70 |
| 3rd UP Forecast | 448.90 |
| 2nd UP Forecast | 410.70 |
| 1st UP Forecast | 372.50 |
| 1st DOWN Forecast | 263.50 |
| 2nd DOWN Forecast | 225.30 |
| 3rd DOWN Forecast | 187.10 |
| 4th DOWN Forecast | 125.30 |
6446 Forecast2025
| 4th UP Forecast | 942.35 |
| 3rd UP Forecast | 742.12 |
| 2nd UP Forecast | 618.35 |
| 1st UP Forecast | 494.58 |
| 1st DOWN Forecast | 141.42 |
| 2nd DOWN Forecast | 17.65 |
| 3rd DOWN Forecast | -106.12 |
| 4th DOWN Forecast | -306.35 |
PharmaEssentia Corporation ( TWO Taiwan Symbol : 6446 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
6446 Business Profile
PharmaEssentia Corporation engages in the research, development, production, and sale of therapeutic products for the treatment of human diseases. Its products include ropeginterferon alfa-2b that is used for the treatment of polycythemia vera, essential thrombocythemia, and hepatitis B and C; and Anti-PD-1 antibody for the treatment of cancer. The company also licensed to develop Oraxol for the treatment of breast, advanced gastric, and esophageal cancer; KX01 for the treatment of psoriasis and actinic keratosis. It also focuses on the drug research and development programs in the areas of hematology, infectious disease, oncology, and dermatology. The company has a research collaboration agreement with Axis Therapeutics Limite for the development of T Cell Receptor-T therapy based on the T cell receptor affinity enhancing specific T cell therapy technology platform. PharmaEssentia Corporation was founded in 2003 and is headquartered in Taipei, Taiwan. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service